CAPTRUST Financial Advisors’s Zymeworks ZYME Stock Holding History

CAPTRUST Financial Advisors’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-500	Closed	-$15K	–	4942
2021 Q3	$15K	Hold	500	–	–	﹤0.01%	3368
2021 Q2	$17K	Hold	500	–	–	﹤0.01%	3230
2021 Q1	$16K	Hold	500	–	–	﹤0.01%	3163
2020 Q4	$24K	Hold	500	–	–	﹤0.01%	2173
2020 Q3	$23K	Hold	500	–	–	﹤0.01%	1917
2020 Q2	$18K	Buy	+500	New	+$18.4K	﹤0.01%	1988

Other funds holding ZYME

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

CAPTRUST Financial Advisors's ZYME Position: Q4 2021 in Review

CAPTRUST Financial Advisors sold out of Zymeworks (ZYME) in Q4 2021, closing a stake of 500 shares — an estimated $15K sold.

CAPTRUST Financial Advisors first reported a position in ZYME in Q2 2020 and held it in 6 quarters. The position peaked at $24K in Q4 2020. 114 funds tracked by Wall St. Rank hold ZYME as of Q4 2021.

CAPTRUST Financial Advisors reported no remaining Zymeworks position as of Q4 2021 after selling out during the quarter.
CAPTRUST Financial Advisors sold 500 Zymeworks shares in Q4 2021, an estimated $15K.
CAPTRUST Financial Advisors first reported a position in Zymeworks in Q2 2020 and held it in 6 quarters.
CAPTRUST Financial Advisors's Zymeworks position peaked at $24K in Q4 2020.
114 funds tracked by Wall St. Rank held Zymeworks as of Q4 2021.

Based on CAPTRUST Financial Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.